Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.285
+0.015 (1.18%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Editas Medicine Employees
Editas Medicine had 246 employees as of December 31, 2024. The number of employees decreased by 19 or -7.17% compared to the previous year.
Employees
246
Change (1Y)
-19
Growth (1Y)
-7.17%
Revenue / Employee
$131,358
Profits / Employee
-$963,793
Market Cap
106.21M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
EDIT News
- 4 weeks ago - Editas Medicine Announces Chief Financial Officer Transition - GlobeNewsWire
- 5 weeks ago - Editas Medicine, Inc. (EDIT) Barclays 27th Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 5 weeks ago - Editas Medicine, Inc. (EDIT) Leerink Partners Global Healthcare Conference (Transcript) - Seeking Alpha
- 6 weeks ago - Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates - GlobeNewsWire
- 6 weeks ago - Editas Medicine, Inc. (EDIT) TD Cowen 45th Annual Health Care Conference Transcript - Seeking Alpha
- 7 weeks ago - Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March - GlobeNewsWire
- 3 months ago - Editas And Intellia: Strategic Shifts And Long-Term Investment Potential - Seeking Alpha
- 3 months ago - Editas Medicine, Inc. (EDIT) 43rd Annual JPMorgan Healthcare Conference - (Transcript) - Seeking Alpha